{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Micardis+placebo", "query": { "intervention": "Micardis placebo" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 17, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Micardis+placebo&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-15T18:45:57.579Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00153101", "title": "Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cardiovascular Diseases" ], "interventions": [ { "name": "Telmisartan", "type": "DRUG" }, { "name": "Combination of Telmisartan and Ramipril", "type": "DRUG" }, { "name": "Ramipril", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 31546, "start_date": "2001-11", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-05-20", "last_synced_at": "2026-09-15T18:45:57.579Z", "location_count": 100, "location_summary": "Athens, Alabama • Birmingham, Alabama • Phoenix, Arizona + 84 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00153101" }, { "nct_id": "NCT01885559", "title": "HALT Progression of Polycystic Kidney Disease Study B", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Kidney, Polycystic" ], "interventions": [ { "name": "Lisinopril", "type": "DRUG" }, { "name": "Telmisartan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "15 Years to 64 Years" }, "enrollment_count": 486, "start_date": "2006-01", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2020-04-22", "last_synced_at": "2026-09-15T18:45:57.579Z", "location_count": 7, "location_summary": "Aurora, Colorado • Atlanta, Georgia • Kansas City, Kansas + 3 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01885559" }, { "nct_id": "NCT02471833", "title": "Health Evaluation in African Americans Using RAS Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "Telmisartan 20mg", "type": "DRUG" }, { "name": "Telmisartan 40mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 61, "start_date": "2015-04", "completion_date": "2022-04-15", "has_results": true, "last_update_posted_date": "2024-05-23", "last_synced_at": "2026-09-15T18:45:57.579Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02471833" }, { "nct_id": "NCT00153062", "title": "PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Stroke" ], "interventions": [ { "name": "Aggrenox", "type": "DRUG" }, { "name": "Clopidogrel placebo", "type": "DRUG" }, { "name": "Micardis", "type": "DRUG" }, { "name": "Aggrenox placebo", "type": "DRUG" }, { "name": "Clopidogrel", "type": "DRUG" }, { "name": "Micardis placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 20332, "start_date": "2003-08", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-05-13", "last_synced_at": "2026-09-15T18:45:57.579Z", "location_count": 204, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 160 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Northport", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00153062" }, { "nct_id": "NCT00981526", "title": "Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder" ], "interventions": [ { "name": "Telmisartan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Clozapine", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Massachusetts, Worcester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 66, "start_date": "2009-03", "completion_date": "2012-05", "has_results": true, "last_update_posted_date": "2018-06-19", "last_synced_at": "2026-09-15T18:45:57.579Z", "location_count": 1, "location_summary": "Worcester, Massachusetts", "locations": [ { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00981526" }, { "nct_id": "NCT01683084", "title": "Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Abdominal Aortic Aneurysm" ], "interventions": [ { "name": "Telmisartan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Palo Alto Veterans Institute for Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 22, "start_date": "2012-09-19", "completion_date": "2018-11-10", "has_results": false, "last_update_posted_date": "2020-05-26", "last_synced_at": "2026-09-15T18:45:57.579Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01683084" }, { "nct_id": "NCT00281580", "title": "Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Amlodipine 5 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Telmisartan 20 mg", "type": "DRUG" }, { "name": "Telmisartan 40 mg", "type": "DRUG" }, { "name": "Amlodipine 10 mg", "type": "DRUG" }, { "name": "Telmisartan 80 mg", "type": "DRUG" }, { "name": "Amlodipine 2.5 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1461, "start_date": "2006-04", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-03-27", "last_synced_at": "2026-09-15T18:45:57.579Z", "location_count": 101, "location_summary": "Fairhope, Alabama • Huntsville, Alabama • Chandler, Arizona + 81 more", "locations": [ { "city": "Fairhope", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00281580" }, { "nct_id": "NCT00146289", "title": "The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Obesity", "Insulin Resistance" ], "interventions": [ { "name": "MICARDIS® (telmisartan)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 138, "start_date": "2005-02", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-11-01", "last_synced_at": "2026-09-15T18:45:57.579Z", "location_count": 8, "location_summary": "Los Angeles, California • San Diego, California • Westlake Village, California + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Westlake Village", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00146289" }, { "nct_id": "NCT04360551", "title": "Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Telmisartan 40mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Hawaii", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2020-07-01", "completion_date": "2022-04-26", "has_results": true, "last_update_posted_date": "2023-08-21", "last_synced_at": "2026-09-15T18:45:57.579Z", "location_count": 1, "location_summary": "Honolulu, Hawaii", "locations": [ { "city": "Honolulu", "state": "Hawaii" } ], "official_url": "https://clinicaltrials.gov/study/NCT04360551" }, { "nct_id": "NCT00240448", "title": "A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "telmisartan 80 mg/hydrochlorothiazide 25 mg", "type": "DRUG" }, { "name": "valsartan 160 mg/hydrochlorothiazide 25 mg", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1109, "start_date": "2003-09", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-11-05", "last_synced_at": "2026-09-15T18:45:57.579Z", "location_count": 100, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 90 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Sctoosdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00240448" } ] }